Defunct Company
Total Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
2,081
NCT01119105
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Phase: Phase 2
Role: Lead Sponsor
Start: May 31, 2010
Completion: Feb 3, 2011
NCT02557789
Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects
Phase: Phase 1
Start: Jun 30, 2015
Completion: Jun 30, 2015
NCT02559310
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
Phase: Phase 3
Start: Sep 30, 2015
Completion: May 31, 2017
NCT02753946
Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections
Phase: Phase 2/3
Start: Apr 30, 2016
Completion: May 30, 2017
NCT02813694
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Start: Aug 31, 2016
Completion: Jan 31, 2018
NCT03131141
A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781
Start: Jan 8, 2017
Completion: Mar 30, 2018
NCT03709927
4-way Crossover QT Evaluation in Healthy Subjects
Start: Jan 11, 2018
Completion: Aug 21, 2018
NCT03709914
PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)
Start: May 24, 2018
Completion: Jan 10, 2026
NCT05225805
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
Start: Mar 1, 2022
Completion: Jan 13, 2023
NCT05111002
Lefamulin for M. Genitalium Treatment Failures
Phase: Phase 1/2
Role: Collaborator
Start: Apr 22, 2022
Completion: Nov 30, 2023